|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
Elan Corporation acquired by Perrigo Company in 2013
acquired by Perrigo Company
acquired by Perrigo Company in 2013
acquired by Perrigo Company in 2014
acquired by Perrigo Company in 2015
acquired by Perrigo Company in 2016
acquired by Perrigo Company in 2017
acquired by Perrigo Company in 2018
acquired by Perrigo Company in 2019
acquired by Perrigo Company in 2020
acquired by Perrigo Company in 2021
acquired by Perrigo Company in 2022
acquired by Perrigo Company in 2023
|
|
gptkbp:ceo
|
gptkb:K._J._Mc_Carthy
gptkb:Kelly_Martin
gptkb:D._J._O'_Connor
|
|
gptkbp:dissolved
|
gptkb:2014
|
|
gptkbp:employees
|
approximately 1,000
|
|
gptkbp:founded
|
gptkb:1969
|
|
gptkbp:founder
|
gptkb:K._J._Mc_Carthy
|
|
gptkbp:headquarters
|
gptkb:Dublin
gptkb:Dublin,_Ireland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Elan Corporation
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:location
|
gptkb:Ireland
|
|
gptkbp:notable_products
|
gptkb:Tysabri
gptkb:Prialt
|
|
gptkbp:partnership
|
gptkb:Johnson_&_Johnson
gptkb:Pfizer
|
|
gptkbp:products
|
biopharmaceuticals
drug delivery systems
neurodegenerative disease treatments
|
|
gptkbp:research_focus
|
gptkb:Crohn's_disease
gptkb:neurodegenerative_diseases
gptkb:multiple_sclerosis
Huntington's disease
|
|
gptkbp:revenue
|
$1.2 billion (2012)
|
|
gptkbp:stock_exchange
|
gptkb:NASDAQ
|
|
gptkbp:subsidiary
|
gptkb:Elan_Drug_Technologies
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.elan.com
|
|
gptkbp:bfsParent
|
gptkb:Biogen_Inc.
gptkb:BIIB
|
|
gptkbp:bfsLayer
|
5
|